国家指南发布后基层医疗对前列腺癌筛查的看法：一项问卷调查

Primary care perspective of prostate cancer screening after national guidance: a questionnaire survey.

作者信息

Kalsi G S, Rajaratnam G, Bridgman S A

机构信息

Department of Public Health and Health Policy, Sheffield Health Authority, UK.

出版信息

J Med Screen. 2000;7(2):116-7. doi: 10.1136/jms.7.2.116.

DOI:10.1136/jms.7.2.116

PMID:11002455

Abstract

National guidance (executive letter) EL(97)12 stated that population screening should not be provided by the NHS, or be offered to the public until there is effective screening technology for prostate cancer. The study set out to determine the views of general practitioners and, indirectly, their practice staff on prostate cancer screening in primary care upon receiving EL(97)12. This postal questionnaire survey reveals that 81% (95% CI 75% to 87%) of responding general practitioners in North Staffordshire agreed with EL(97)12 and one in ten said that the executive letter changed their views, suggesting that such national guidance has an effect.

摘要

国家指导意见（行政信函）EL(97)12指出，在尚无有效的前列腺癌筛查技术之前，国民保健服务体系（NHS）不应开展人群筛查，也不应向公众提供此项服务。该研究旨在确定全科医生及其执业人员在收到EL(97)12后对初级医疗保健中前列腺癌筛查的看法。这项邮寄问卷调查显示，北斯塔福德郡81%（95%置信区间为75%至87%）做出回应的全科医生赞同EL(97)12，十分之一的人表示行政信函改变了他们的看法，这表明此类国家指导意见具有影响力。